相似文献
1
E-rosette-forming cells at 29 degrees C: an assay for the evaluation of the immune status of cancer patients.
Br J Cancer. 1978 Nov;38(5):606-11. doi: 10.1038/bjc.1978.256.
2
Mixed rosette assay for the detection of T mu and T gamma lymphocytes.
J Immunol Methods. 1980;36(3-4):197-209. doi: 10.1016/0022-1759(80)90125-8.
3
Low affinity E-rosette formation by the human K cell.
J Immunol. 1978 Jan;120(1):90-5.
4
Human autologous rosettes. II. Prognostic significance of variations in autologous rosette-forming cells in the peripheral blood of cancer patients.
J Natl Cancer Inst. 1979 Sep;63(3):593-7. doi: 10.1093/jnci/63.3.593.
5
Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases.
J Clin Invest. 1973 May;52(5):1026-32. doi: 10.1172/JCI107267.
6
Increased stability of E-rosettes and restricted capping of sheep erythrocytes by lymphocytes of aged humans.
Mech Ageing Dev. 1982 Jan;18(1):47-52. doi: 10.1016/0047-6374(82)90028-8.
7
Decreased autologous rosette-forming T lymphocytes in alcoholic cirrhosis: absence of correlation with other T cell markers and with delayed cutaneous hypersensitivity.
Int Arch Allergy Appl Immunol. 1980;61(3):337-43. doi: 10.1159/000232456.
8
Increased proportion of active sheep erythrocyte rosette-forming lymphocytes and plasma rosette enhancement in sarcoidosis.
Am Rev Respir Dis. 1979 Mar;119(3):383-9. doi: 10.1164/arrd.1979.119.3.383.
9
Active T-rosette-forming cells in the peripheral blood of cancer patients.
Cancer Res. 1976 Sep;36(9 pt.1):3274-8.
10
The effect of varying SRBC/lymphocyte ratio on T cell rosette formation.
Arch Immunol Ther Exp (Warsz). 1978;26(1-6):347-9.
引用本文的文献
1
Lymphoid cells in lymph nodes and peripheral blood of patients with squamous cell carcinoma of the head and neck.
J Cancer Res Clin Oncol. 1982;102(3):277-87. doi: 10.1007/BF00411348.
本文引用的文献
1
Crohn's disease and carcinoma of colon.
Br Med J. 1968 May 25;2(5603):466-8. doi: 10.1136/bmj.2.5603.466.
2
Crohn's disease and cancer.
N Engl J Med. 1973 Nov 22;289(21):1099-103. doi: 10.1056/NEJM197311222892101.
3
Cell-mediated immune status of breast cancer patients: evaluation by skin tests, lymphocyte stimulation, and counts of rosette-forming cells.
J Natl Cancer Inst. 1974 Sep;53(3):641-5. doi: 10.1093/jnci/53.3.641.
4
T lymphocytes in bladder and prostatic cancer patients.
J Urol. 1974 Sep;112(3):378-82. doi: 10.1016/s0022-5347(17)59735-9.
5
Thymus-derived rosette-forming cells in various human disease states: cancer, lymphoma, bacterial and viral infections, and other diseases.
J Clin Invest. 1973 May;52(5):1026-32. doi: 10.1172/JCI107267.
6
New formulation of digoxin.
Lancet. 1972 Oct 28;2(7783):922-3.
7
Performance of a rosette assay between lymphocytes and sheep erythrocytes at elevated temperatures to study patients with cancer and other diseases.
Clin Immunol Immunopathol. 1976 Jan;5(1):60-6. doi: 10.1016/0090-1229(76)90149-5.
8
The significance of varying SRBC/lymphocyte ratio in T cell rosette formation.
J Immunol. 1976 May;116(5):1397-9.
9
A modified assay for the detection of human adult active rosette forming lymphocytes.
J Immunol Methods. 1975;8(1-2):175-84. doi: 10.1016/0022-1759(75)90094-0.
10
Demonstration of nonspecific suppressor cells in the peripheral lymphocytes of cancer patients.
Cancer Res. 1978 Feb;38(2):288-96.
Zotero 插件